EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Image-localized biopsy mapping of brain tumor heterogeneity: A single-center study protocol

Javier C Urcuyo iD, Lee Curtin iD, Jazlynn M Langworthy iD, Gustavo De Leon, Barrett Anderies, Kyle W Singleton, Andrea Hawkins-Daarud, Pamela R Jackson, Kamila M Bond, Sara Ranjbar, Yvette Lassiter-Morris, Kamala R Clark-Swanson und 25 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0287767 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS ONE, 2023. Verfasst von Javier C Urcuyo und 36 weiteren Autor:innen. Beteiligte Einrichtung: Mathematical NeuroOncology Lab, Mayo Clinic, Phoenix, Arizona, United States of America. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, Ben and Catherine Ivy Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brain cancers pose a novel set of difficulties due to the limited accessibility of human brain tumor tissue. For this reason, clinical decision-making relies heavily on MR imaging interpretation, yet the mapping between MRI features and underlying biology remains ambiguous. Standard (clinical) tissue sampling fails to capture the full heterogeneity of the disease. Biopsies are required to obtain a pathological diagnosis and are predominantly taken from the tumor core, which often has different traits to the surrounding invasive tumor that typically leads to recurrent disease. One approach to solving this issue is to characterize the spatial heterogeneity of molecular, genetic, and cellular features of glioma through the intraoperative collection of multiple image-localized biopsy samples paired with multi-parametric MRIs. We have adopted this approach and are currently actively enrolling patients for our ‘Image-Based Mapping of Brain Tumors’ study. Patients are eligible for this research study (IRB #16–002424) if they are 18 years or older and undergoing surgical intervention for a brain lesion. Once identified, candidate patients receive dynamic susceptibility contrast (DSC) perfusion MRI and diffusion tensor imaging (DTI), in addition to standard sequences (T1, T1Gd, T2, T2-FLAIR) at their presurgical scan. During surgery, sample anatomical locations are tracked using neuronavigation. The collected specimens from this research study are used to capture the intra-tumoral heterogeneity across brain tumors including quantification of genetic aberrations through whole-exome and RNA sequencing as well as other tissue analysis techniques. To date, these data (made available through a public portal) have been used to generate, test, and validate predictive regional maps of the spatial distribution of tumor cell density and/or treatment-related key genetic marker status to identify biopsy and/or treatment targets based on insight from the entire tumor makeup. This type of methodology, when delivered within clinically feasible time frames, has the potential to further inform medical decision-making by improving surgical intervention, radiation, and targeted drug therapy for patients with glioma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGliomaHumansDiffusion Tensor ImagingMagnetic Resonance ImagingBiopsyBrainBrain Mapping

Autor:innen und Institutionen

  • Mathematical NeuroOncology Lab, Mayo Clinic, Phoenix, Arizona, United States of America.
  • Department of Neurosurgery, Mayo Clinic, Phoenix, Arizona, United States of America.
  • Department of Cancer Biology, Mayo Clinic, Phoenix, Arizona, United States of America.
  • Department of Neurology, Mayo Clinic, Phoenix, Arizona, United States of America.
  • Department of Oncology, Mayo Clinic, Phoenix, Arizona, United States of America.
  • Department of Neurophysiology, Mayo Clinic, Phoenix, Arizona, United States of America.

ORCID-Profile: Javier C Urcuyo, Lee Curtin, Jazlynn M Langworthy, Kristin R Swanson

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Ben and Catherine Ivy Foundation
  • James S. McDonnell Foundation
  • National Science Foundation
  • Zicarelli Foundation

Zitieren

APA

Urcuyo, J. C., Curtin, L., Langworthy, J. M., De Leon, G., Anderies, B., Singleton, K. W., Hawkins-Daarud, A., Jackson, P. R., Bond, K. M., Ranjbar, S., Lassiter-Morris, Y., Clark-Swanson, K. R., Paulson, L. E., Sereduk, C., Mrugala, M. M., Porter, A. B., Baxter, L., Salomao, M., Donev, K., …, & Swanson, K. R. (2023). Image-localized biopsy mapping of brain tumor heterogeneity: A single-center study protocol. PLOS ONE. https://doi.org/10.1371/journal.pone.0287767

Vancouver

Urcuyo JC, Curtin L, Langworthy JM, De Leon G, Anderies B, Singleton KW, et al. Image-localized biopsy mapping of brain tumor heterogeneity: A single-center study protocol. PLOS ONE. 2023. doi:10.1371/journal.pone.0287767

BibTeX
@article{Urcuyo2023,
  author = {Urcuyo, Javier C and Curtin, Lee and Langworthy, Jazlynn M and De Leon, Gustavo and Anderies, Barrett and Singleton, Kyle W and Hawkins-Daarud, Andrea and Jackson, Pamela R and Bond, Kamila M and Ranjbar, Sara and Lassiter-Morris, Yvette and Clark-Swanson, Kamala R and Paulson, Lisa E and Sereduk, Chris and Mrugala, Maciej M and Porter, Alyx B and Baxter, Leslie and Salomao, Marcela and Donev, Kliment and Hudson, Miles and Meyer, Jenna and Zeeshan, Qazi and Sattur, Mithun and Patra, Devi P and Jones, Breck A and Rahme, Rudy J and Neal, Matthew T and Patel, Naresh and Kouloumberis, Pelagia and Turkmani, Ali H and Lyons, Mark and Krishna, Chandan and Zimmerman, Richard S and Bendok, Bernard R and Tran, Nhan L and Hu, Leland S and Swanson, Kristin R},
  title = {Image-localized biopsy mapping of brain tumor heterogeneity: A single-center study protocol},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0287767}
}
Kostenlos starten →